Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression

Breast Cancer Research and Treatment

Volumn 43, Issue 2, 1997, Pages 175-181

  Rha, Sun Young ^a   Kim, Joo Hang ^a   Roh, Jae Kyung ^a   Lee, Kyong Sik ^a   Min, Jin Sik ^a   Kim, Byung Soo ^a   Chung, Hyun Cheol ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Breast cancer; Invasion; MMP 9; Zymography

Indexed keywords

ENZYME PRECURSOR; GELATINASE B;

ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; COLLAGENASES; DISEASE PROGRESSION; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 0030946003     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005701231871     Document Type: Article

References (29)

1. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteases: a common theme in tumor cell invasion and angiogenesis. Biochem Biophys Acta 948: 67-85, 1988
2. Tryggvason K, Hoyhtya M, Pyke C: Type IV collagenases in invasive tumors. Br Cancer Res Treat 24: 209-218, 1993
3. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metast Rev 289-303, 1990
4. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV-40-transformed human lung fibroblasts secrete a 92-kd type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264: 17213-17219, 1989
5. Miyajima Y, Nakano R, Morimatsu M: Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104: 678-684, 1995
6. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano K: 92 KDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65: 57-62, 1996
7. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F: Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196, 1996
8. Daidone MG, Silvestrini R, Derrico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA, Grigioni WF: Laminin receptors, collagenase IV and prognosis in node negative breast cancers. Int J Cancer 48: 529-532, 1991
9. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG: Immunohistochemical distribution and type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 136: 585-592, 1990
10. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994
11. Fridman R, Toth M, Pena D, Mobashery S: Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55: 2548-2555, 1995
12. Huessen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gel containing sodium dodecyl sulphate and co-polymerized substrates. Ann Biochem 102: 196-202, 1980
13. Kleiner DE, Stetler-Stevenson WG: Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329, 1994
14. Beahrs OH, Meyers MH: Manual for Staging of Cancer, 4th ed. Lippincott, Philadelphia, 1992, 148 pp
15. Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191, 1990
16. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s, 1991
17. Stetler-Stevenson WG, Krutzsch HC, Wachner MP, Marguiles IMK, Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353-1356, 1989
18. Polette M, Gilbert N, Stat I, Nawrocki B, Noel A, Remarcle A. Stetler-Stevenson WG, Birembaut P, Foidart M: Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Archiv 424: 641-645, 1994
19. Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A, Autio-Harmainen H: 72 kD and 92 RD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem 42: 945-951. 1994
20. Van der Stappen JW, Hendriks T, Wobbes T: Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 45: 1071-1078. 1990
21. Zeng ZS, Guillem JG: Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastasis. Br J Cancer 72: 575-582, 1995
22. Otani Y: The collagenase activities, interstitial collagenase and type IV collagenase in human stomach cancer: with special reference to local spreading and lymph node metastasis. Keio J Med 39: 159-167, 1990
23. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69: 9-16, 1996
24. Davis B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG. Rubens RD, Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993
25. Brown PD, Bloxidge RE, Anderson E, Howell A: Expression of activated gelatinase in human invasion breast carcinoma. Clin Exp Metastasis 11: 183-189, 1993
26. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J: Association between expression of activated 72 kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst 85: 574-578, 1993
27. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994
28. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993
29. Wolf C, Rouyer N, Yves L, Colette A, Loriot M, Bellocq JP, Chambon P. Basset P: Stromelysin 3 belongs to subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90: 1843-1847, 1993